Anti-Prostate Cancer Activity of 8-Hydroxyquinoline-2-Carboxaldehyde-Thiosemicarbazide Copper Complexes by...

Area of Science:

• Inorganic Chemistry
• Medicinal Chemistry
• Cancer Biology

Background:

• Copper thiosemicarbazone complexes exhibit anticancer properties.
• Cisplatin-resistant neuroblastoma cells are a known target for these complexes.
• Prostate cancer remains a significant health concern requiring novel therapeutic strategies.

Purpose of the Study:

• To evaluate the in vitro anti-prostate cancer activity of copper 8-hydroxyquinoline-2-carboxaldehyde-thiosemicarbazide (CuHQTS) and copper 8-hydroxyquinoline-2-carboxaldehyde-4,4-dimethyl-3-thiosemicarbazone (CuHQDMTS).

Main Methods:

• In vitro assessment of prostate cancer cell proliferation inhibition by CuHQTS and CuHQDMTS.
• Cytotoxicity evaluation using fluorescent microscopic imaging on prostate cancer cells engineered to express green fluorescent protein (GFP).

Main Results:

• Both CuHQTS and CuHQDMTS effectively inhibited prostate cancer cell proliferation.
• Significant cytotoxicity was observed for both copper complexes against GFP-expressing prostate cancer cells.
• Fluorescent microscopic imaging proved effective for visualizing the anticancer effects.

Conclusions:

• CuHQTS and CuHQDMTS exhibit promising anti-prostate cancer activity.
• GFP-expressing prostate cancer cells offer a viable model for evaluating the efficacy of copper-based anticancer agents using fluorescent microscopy.